Cancer Research UK logo.
SearchDonate
  • Search

A trial of sunitinib and nivolumab for sarcoma (ImmunoSarc2)

Overview

Cancer types:

Bone cancer, Children's cancers, Sarcoma, Soft tissue sarcoma

Status:

Closed

Phase:

Phase 1/2

Details

This trial is looking at sunitinib with nivolumab. It is for children, teenagers and adults whose soft tissue sarcoma or bone sarcoma has come back after treatment.

We use the term ‘you’ in this summary but if you are a parent we are referring to your child.

Recruitment start: 6 October 2021

Recruitment end: 28 June 2024

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Sandra Strauss

Supported by

University College London Hospitals NHS Foundation Trust

Grupo Español de Investigación en Sarcomas (GEIS)

The Jon Moulton Charity Trust

Pfizer

Bristol-Myers Squibb

Last reviewed: 27 June 2024

CRUK internal database number: 17861

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.